Results

Coronary Artery Calcifications
Overall, 982 women had CAC assessment at the year 20 examination. They included 55 women with PCOS, 156 women with IH, 103 women with IO, and 668 women with neither oligomenorrhea nor hyperandrogenism (controls; Table 1 ). This study population, aged 45.3 years, comprised 51% black women (range, 36% among the PCOS group to 56% among the oligomenorrhea group). Body mass index (BMI) ranged between 29.3 (PCOS group) and 30.5 kg/m 2 (IH group). Glucose and insulin measurements were highest among women with PCOS, leading to Homeostasis Model Assessment-insulin resistance (HOMA-IR) of 5.32 in the PCOS group when compared with that of 3.66 to 3.99 in the other study groups (Table 1) .
CAC was present in 10.3% of the controls, 11.7% of women with IO, 6 .4% of women with IH, and 23.6% of women with PCOS. Women with PCOS had an odds ratio (OR) of 2.69 (95% confidence interval [CI], 1.37-5.25) for having CAC, whereas no significant association was found for the other study groups (P for interaction between oligomenorrhea and hyperandrogenism, 0.015; Table 2 ). The association between PCOS and CAC remained similar in multivariable models controlling for age, race, education, smoking, menopausal status, BMI, systolic blood pressure, triglycerides, and HOMA-IR (Table 2) . Results were unaltered when treatments for hypercholesterolemia or diabetes mellitus were introduced, and they were slightly attenuated when controlled for the metabolic syndrome (PCOS associated OR, 2.57; 95% CI, 1.28-5.28; not shown). The association became somewhat stronger when Agatston score >10 was considered as CAC positive (adjusted OR, 2.91; 95% CI, 1.21-6.98) rather than Agatston score >0.
Carotid-IMT
Carotid-IMT assessments were conducted in 988 women for whom information on PCOS status was available. Table 3 presents the adjusted means according to the general linear models of carotid-IMT by segment. In analyses examining the associations of PCOS and its components with carotid-IMT at year 20, no association was found among IO, IH, or the combination of oligomenorrhea and hyperandrogenism (PCOS) and the IMT of the common carotid artery (CCA-IMT).
Women with IO or IH had similar IMTs of the bulb or the internal carotid artery (Bulb-IMT and ICA-IMT) when compared with controls. However, women who had PCOS in their twenties had increased Bulb-IMT and ICA-IMT. The adjusted means for Bulb-IMT were 0.96, 0.98, 0.93, and 1.05 mm, for women who were unexposed, with IO, IH, or PCOS, respectively. Adjusted means of ICA-IMT were 0.77, 0.76, 0.78, and 0.83 mm, for women who were controls, with IO, IH, or PCOS, respectively (Table 3) . Controlling for the metabolic syndrome did not materially change these results (not shown).
In logistic regression analyses adjusted for age, race, education, smoking, menopausal status, BMI, systolic blood pressure, triglycerides, and HOMA-IR, the ORs for the highest quintile of internal carotid-IMT versus the lowest 4 were 0.70 (0.38-1.30) for oligomenorrhea, 0.80 (0.49, 1.33) for hyperandrogenism, and 2.00 (1.07, 3.75) for PCOS (P for interaction between oligomenorrhea and hyperandrogenism, 0.010; Table 4 ). Controlling for the metabolic syndrome yielded similar results (not shown).
Discussion
In a population-based, multicenter, biracial cohort of young adult women, we found an increased risk of subclinical CVD, assessed at a mean age of 45 years, among women with evidence of PCOS in their twenties when compared with those who had neither oligomenorrhea nor hyperandrogenism. There was no evidence of increased risk of subclinical CVD among women with either IO or IH.
To date, only few studies have described the association between PCOS and CAC. In a study by Talbott et al, 27 the age-and BMI-adjusted OR for CAC≥10 was 1.90, among 149 women with PCOS and 166 controls; differences in median coronary calcium Agatson score between PCOS cases and controls were modified by menopausal status, with the largest differences observed among postmenopausal women, and especially those with surgically induced menopause. A recent analysis of this study population suggested increased OR also for CAC>0, and no mediation by complement levels. 28 Christian et al 17 20 the prevalence of CAC score >10 was similar among women with PCOS defined as having both oligomenorrhea and hyperandrogeneism (n=55), or alternately, according to the Rotterdam criteria (n=144) and normal ovulatory controls (n=170), despite a higher prevalence of CVD risk factors among women with PCOS. Although we focused our analyses on a more liberal definition of CAC (Agatston score >0), sensitivity analyses defining CAC positive as Agatston score >10 showed a higher prevalence of CAC among women with PCOS (16.4%) when compared with controls (6.4%), with the association remaining elevated after adjustment for potential confounders. Differences in results between the 2 studies could reflect either differences in prevalence of CVD risk factors or differences in definitions of PCOS (eg, age of testosterone assessment).
We found an association between PCOS and bulb-IMT and ICA-IMT but not with CCA-IMT. The bulb and ICA segments are more common sites for the development of carotid plaques than the CCA. 29 Shedding light on the mechanism of ICA-and Bulbar-IMT thickening is important because these segments may be most predictive of future atherosclerotic events. In the CHS study, prevalent atherosclerotic disease in general and coronary heart disease, in particular, were more strongly associated with ICA-IMT than the other 2 segments. 30 Furthermore, in a cohort study of 6226 men and women, during 6 years of follow-up, a composite IMT measure of all segments was strongly associated with incident acute myocardial infarction in women, whereas analyses restricted to the CCA-IMT alone showed no association, suggesting that the bulb-IMT and ICA-IMT are the carotid segments that are most useful in predicting atherosclerotic events in women. 31 Although traditional CVD risk factors contribute to IMT thickening overall, Numbers represent means (SD), unless stated otherwise. BMI indicates body mass index; DBP, diastolic blood pressure; HDL-C, high-density lipoprotein cholesterol; HOMA-IR, Homeostasis Model Assessment-insulin resistance; LDL-C, low-density lipoprotein cholesterol; PCOS, polycystic ovary syndrome; and SBP, systolic blood pressure.
*Defined according to medical treatments for the condition. †Defined according to the joint interim definition (2009) as having ≥3 of waist circumference (>88 cm), increased blood pressure (SBP≥135, DBP≥85, or treatment for hypertension), increased glucose (fasting glucose≥100 mg/dL or taking medications for diabetes), increased triglycerides (≥1.7 mmol/L), and decreased HDL-C (<1.3 mmol/L).
‡Self-reported history of acute myocardial infarction or angina.
these CVD risk factors seem to contribute more to the thickening of the CCA than to the thickening of the ICA and bulb segments. In an earlier report from the CARDIA study that used data from both men and women, cardiovascular risk factors explained a larger proportion of the CCA-IMT variability (26.8%) than the bulb (11.2%) or ICA (8.0%). 32 Furthermore, in The Vascular Aging (EVA) study, systolic blood pressure and hypertension were associated with both CCA-IMT and plaques at the Bulb and ICA; however, diabetes mellitus, lowdensity lipoprotein cholesterol, and high-density lipoprotein cholesterol were associated only with CCA-IMT. 33 Similarly, among Taiwanese women, the metabolic syndrome was only associated with CCA-IMT, but not with the bulbar or ICA-IMT. 34 However, in the Multi-Ethnic Study of Atherosclerosis (MESA) study, among 997 adults aged 45 to 84 years, the metabolic syndrome was associated with both CCA-IMT and the ICA-IMT. 35 Finally, these associations may be age and sex related, as shown in a recent meta-analysis that demonstrated associations of triglycerides and high-density lipoprotein cholesterol with CCA-IMT. However, the association of triglycerides was not evident among women, and the negative association of high-density lipoprotein cholesterol was not evident among those aged <60 years. 36 The few previous studies that have investigated the association between PCOS and carotid-IMT may provide insight. However, most, if not all, of the studies were small. These studies were also typically conducted in clinical settings and compared IMT measurements between patients with PCOS and controls. [21] [22] [23] [24] [25] [37] [38] [39] [40] [41] [42] Overall, a meta-analysis reported an increased IMT among women with PCOS, but noted the high heterogeneity among studies. 26 In 2 studies, one by Arikan et al 25 and one by Costa et al, 40 negative results were reported for the association between PCOS and CCA-IMT. Alexandraki et al 41 found no difference in IMT (a combination of the three carotid segments) between 27 young patients with PCOS and overweight and age-and BMImatched controls. However, in a study that compared 125 women with PCOS with 147 controls, Talbott et al. 42 found that PCOS was associated with increased IMT averaged over all 3 segments. This association was found only among participants ≥44 years, suggesting the perimenopausal window as the time period when PCOS women appear at highest risk of atherosclerotic progression.
To the best of our knowledge, our study is the first study to examine the associations of PCOS and its 2 major components, ie, oligomenorrhea and hyperandrogenism, with subclinical CVD. Previous studies investigated either women diagnosed with PCOS or women with either oligomenorrhea or hyperandrogenism, but not as isolated characteristics. Studies of the association of irregular menses, a proxy for oligomenorrhea, with CVD include the study by Solomon et 15 found an increased risk of CHD mortality among women with irregular menses when compared with controls; however, this finding became nonsignificant with adjustment for BMI; risk of mortality from stroke did not differ between the 2 study groups. Both studies referred to irregular menses as a proxy to PCOS.
Studies of the associations between androgens and subclinical CVD have yielded mixed results. A large population-based cross-sectional study of postmenopausal women demonstrated a positive association of total and bioavailable testosterone with CCA-IMT. 43 Conversely, negative results for the association with CCA-IMT were demonstrated by a population-based, cross-sectional study of 483 middle-aged women 44 and in a longitudinal study of 180 postmenopausal women. 45 Moreover, inverse associations of androgens with subclinical CVD were suggested by a cross-sectional study of 101 pre-and postmenopausal women in Italy, 46 and by a nested case-control study within the Atherosclerosis Risk In Communities cohort, where postmenopausal women who had total testosterone levels at the highest quartile had an OR of 0.34 (95% CI, 0.16-0.70) for the highest 5th percentile of a combined IMT measure. 47 We have previously evaluated the association of total and free testosterone as continuous variables with subclinical CVD in the CARDIA Women's Study and found no association for testosterone with either CAC or carotid artery IMT. 48 Women with PCOS in our study tended to have higher fasting insulin and glucose levels (hence higher HOMA-IR), higher triglycerides, and higher prevalence of diabetes mellitus and the metabolic syndrome when compared with the other study groups. Previous studies that looked into different phenotypes of PCOS according to the Rotterdam criteria have found that unlike phenotypes that included both anovulation and hyperandrogenism, the phenotype of hyperandrogenism and sonographic polycystic ovaries was not associated with insulin resistance. 49, 50 It is worth mentioning that in the case of our study, the Rotterdam hyperandrogenism with sonographic polycystic ovaries phenotype is encompassed in our IH group. Thus, combined, ours and other studies suggest that IH does not seem to contribute to insulin resistance or to other cardiometabolic derangements. This points potentially to other hormones or combinations of hormones of the PCOS milieu (such as progesterone, estrogen, and their ratios with androgens) rather than isolated hyperandrogensim as contributors to subclinical CVD associated with PCOS. A hormonal derangement as the cause of the increased risk of CVD in women with PCOS is plausible because the presence of insulin resistance and the metabolic syndrome does not seem to explain much of the association between PCOS and subclinical CVD. This statement is supported by the fact that adjustments for HOMA-IR and other cardiometabolic risk factors only modified the association between PCOS and subclinical CVD measures slightly.
Limitations include the small number of women with PCOS. The definitions of oligomenorrhea and hirsutism when the women were in their twenties were based on self-report and recall. However, self-reported hirsutism and oligomenorrhea have been shown to correlate both with sonographic findings of polycystic ovaries and with hormone levels, supporting their validity in the diagnosis of PCOS. 51, 52 In this study, we found associations of PCOS with ICA and Bulb-IMT, but not with the CCA-IMT. Although the CCA-IMT is the segment most studied that has the highest interobserver reliability, any misclassification of measurements in the bulbar-or the ICA-IMT would be nondifferential by PCOS group, and thus bias the association to the null.
Strengths of this study include a population-based, multicenter study design, with 20 years of follow-up. The classification of women as having PCOS, IH, and isolated anovulation, or none of these conditions was not based on symptoms that motivated women to be referred for clinical diagnosis, but rather on applying a set of criteria to the whole study population.
Our study suggests that women in their twenties with both components of PCOS, but not with either IO or IH, are at increased risk for the development of subclinical CVD. Additional studies are needed to confirm these results and identify the mechanisms that underline these associations. Adjusted for age, race, education, smoking, menopausal status, body mass index, systolic blood pressure, triglycerides, and Homeostasis Model Assessment-insulin resistance. CCA indicates common carotid artery; CI, confidence interval; IMT, intima-media thickness; OR, odds ratio; and PCOS, polycystic ovary syndrome.
*Prevalence of the upper quintile of the segment specific IMT.
